Drug firm Torrent Pharmaceuticals reported Wednesday a 36.31 per cent rise in consolidated net profit to Rs 244 crore for the September ended quarter on robust sales in the domestic market. The company had posted a net profit of Rs 179 crore for the corresponding period of the previous fiscal, Torrent Pharmaceuticals said in a BSE filing.

Consolidated revenue from operations stood at Rs 2,005 crore for the quarter under consideration as against Rs 1,894 crore for the same .